Abstract TP218: Best Practices for Optimizing Door-to-Device Times: Road to Target Stroke Phase III

Thinesh Sivapatham,Barbara J Albani,Kimberly P Gannon,Jason T Nomura,Doug P Huisenga,Mary C Ciechanowski,Reina W McAndrew
DOI: https://doi.org/10.1161/str.55.suppl_1.tp218
IF: 10.17
2024-02-01
Stroke
Abstract:Introduction: The launch of AHA’s Target: Stroke Phase III in 2019 challenged stroke centers to achieve DTD ≤ 90 minutes (direct arriving patients) or ≤ 60 minutes (transfer patients) in ≥ 50% of patients treated with mechanical thrombectomy (MT). At the time of Phase III launch, we were achieving the DTD goal in 45% of patients at our CSC (> 200 MT/year). Methods: Our stroke team, in collaboration with the ED and other relevant departments, analyzed the stroke alert process and implemented changes as needed to improve DTD times: • Early notification of neurointerventional surgery (NIS) by neurologist upon clinical evaluation for any possible MT candidate • CT/CTP/CTA completed simultaneously (IV lytics given in CT if eligible) • Utilization of RAPID.AI platform to allow immediate review of stroke imaging by NIS 24/7 • Decision to upgrade to MT made immediately after imaging completed • MT code activation alerts nursing supervisor, NCCU, anesthesia, and IR team • Patient transported immediately from CT to angio suite by ED nurse upon upgrade 24/7 • ED nurse transfers care to IR team and anesthesia during working hours, or to NCCU nurse and anesthesia during off hours (IR nurse assumes care upon arrival) • Focus on efficient handoff process in angio suite • Specific roles assigned to each team member • Timer on wall started upon patient arrival to angio suite, with arrival to puncture goal < 20 min • Efficiency maintained with simulation MT codes rotating members from IR, ER, NCCU, and anesthesia DTD times were collected at launch of Phase III in 2019, and after changes were implemented. Objectives were to improve DTD times from baseline, in order to optimize care and achieve Phase III goals. Results: Figure 1. Conclusion: By implementing collaborative and focused interventions, our CSC was able to improve and optimize the workflow of stroke patients undergoing MT, allowing us to achieve the rigorous Target: Stroke Phase III goals and optimize patient outcomes.
peripheral vascular disease,clinical neurology
What problem does this paper attempt to address?